Search Within

Shakeel Modak

  1. "2017"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (9)
Groups
  1. Neuroblastoma Service (24)
  2. Pediatrics, Department of (24)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  4. Center for Hematologic Malignancies (13)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  6. GSK Faculty (13)

More Groups

People
  1. Brian Kushner (13)
  2. Nai-Kong Cheung (13)
  3. Michael La Quaglia (9)
  4. Suzanne Wolden (9)
  5. Ellen Basu (7)
  6. Neeta Pandit-Taskar (7)

More People

Years
  1. 2017 (24)
Publications
  1. Pediatric Blood and Cancer (6)
  2. International Journal of Radiation Oncology, Biology, Physics (4)
  3. Journal of Pediatric Hematology/Oncology (2)
  4. Neuro-Oncology (2)
  5. American Journal of Respiratory and Critical Care Medicine (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (6)
  2. Elsevier Inc. (4)
  3. Lippincott Williams & Wilkins (3)
  4. Oxford University Press (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fosaprepitant use in children and adolescents at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Liu, D.; Horiates, K.; Mathew, S.; Pozotrigo, M.; Thackray, J.; Kussin, M.; Yan, S. Q.; Seyboth, B. M.; Modak, S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Intraperitoneal radioimmunotherapy for desmoplastic small round cell tumor: Results of a PHASE I study (ClinicalTrials.gov identifier NCT01099644)
    Meeting Abstract

    Modak, S.; LaQuaglia, M. P.; Pandit-Taskar, N.; Zanzonico, P.; Heaton, T.; Lewis, J.; Cheung, N. K.; Carrasquillo, J.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • Dose escalation is needed for gross disease in high-risk neuroblastoma
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; La Quaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Local control with reduced-dose radiation therapy for high-risk neuroblastoma: Results from a prospective trial
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; La Quaglia, M. P.; Basu, E.; Roberts, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Radiation therapy to sites of metastatic disease as part of consolidation in high-risk neuroblastoma: Can long-term control be achieved?
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Assessment of organ dosimetry for planning repeat treatments of high-dose (131)I-MIBG therapy: (123)I-MIBG versus posttherapy (131)I-MIBG imaging
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P.; Hilden, P.; Ostrovnaya, I.; Carrasquillo, J. A.; Modak, S.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival
    Journal Article

    Cheung, I. Y.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    OncoImmunology (2017)

    Fulltext@MSK | Save